EA200901080A1 - Новые нуклеозидные аналоги для лечения вирусных инфекций - Google Patents

Новые нуклеозидные аналоги для лечения вирусных инфекций

Info

Publication number
EA200901080A1
EA200901080A1 EA200901080A EA200901080A EA200901080A1 EA 200901080 A1 EA200901080 A1 EA 200901080A1 EA 200901080 A EA200901080 A EA 200901080A EA 200901080 A EA200901080 A EA 200901080A EA 200901080 A1 EA200901080 A1 EA 200901080A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
viral infections
nucleoside analogues
new nucleoside
new
Prior art date
Application number
EA200901080A
Other languages
English (en)
Russian (ru)
Inventor
Чжэн Инь
Джейарадж Дурайсвами
Уньлян Чэнь
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39462074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200901080(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA200901080A1 publication Critical patent/EA200901080A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA200901080A 2007-02-09 2008-02-07 Новые нуклеозидные аналоги для лечения вирусных инфекций EA200901080A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07102027 2007-02-09
EP08150003 2008-01-02
PCT/EP2008/051527 WO2008095993A1 (en) 2007-02-09 2008-02-07 Novel nucleoside analogs for treatment of viral infections

Publications (1)

Publication Number Publication Date
EA200901080A1 true EA200901080A1 (ru) 2010-02-26

Family

ID=39462074

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901080A EA200901080A1 (ru) 2007-02-09 2008-02-07 Новые нуклеозидные аналоги для лечения вирусных инфекций

Country Status (18)

Country Link
US (1) US8278282B2 (enExample)
EP (1) EP2132216B1 (enExample)
JP (1) JP2010518047A (enExample)
KR (1) KR20090109102A (enExample)
CN (1) CN101600726B (enExample)
AR (1) AR065249A1 (enExample)
AT (1) ATE533774T1 (enExample)
AU (1) AU2008212752A1 (enExample)
BR (1) BRPI0807222A2 (enExample)
CA (1) CA2675462A1 (enExample)
CL (1) CL2008000409A1 (enExample)
EA (1) EA200901080A1 (enExample)
ES (1) ES2381093T3 (enExample)
MX (1) MX2009008495A (enExample)
PE (1) PE20090070A1 (enExample)
PT (1) PT2132216E (enExample)
TW (1) TW200838550A (enExample)
WO (1) WO2008095993A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010015643A1 (en) * 2008-08-06 2010-02-11 Novartis Ag New antiviral modified nucleosides
CN102526087B (zh) * 2010-12-30 2014-09-03 南开大学 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用
CN105669783B (zh) * 2014-12-03 2019-11-12 广东东阳光药业有限公司 一种制备呋喃糖的方法
AU2016301188A1 (en) 2015-08-06 2018-02-15 Chimerix, Inc. Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents
JP6768796B2 (ja) 2015-09-23 2020-10-14 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． ４’−置換ヌクレオシド逆転写酵素阻害剤及びその調製
JP7129703B2 (ja) * 2016-04-28 2022-09-02 エモリー ユニバーシティー アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用
TW201815821A (zh) * 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
JP2019524795A (ja) * 2016-08-12 2019-09-05 ヤンセン バイオファーマ インク． 置換ヌクレオシド、ヌクレオチド、及びそのアナログ
US11111264B2 (en) 2017-09-21 2021-09-07 Chimerix, Inc. Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof
WO2020219447A1 (en) 2019-04-23 2020-10-29 Elementis Specialties, Inc. Slurry compositions containing mixed branched alkyl organoclay compositions
EP4454650A4 (en) * 2021-12-22 2025-10-22 Cj Cheiljedang Corp ANTIVIRAL COMPOSITION COMPRISING NUCLEOSIDE ANALOGUES DERIVED FROM A NUCLEIC ACID AND A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
WO2024012568A1 (en) * 2022-07-15 2024-01-18 Sunshine Lake Pharma Co., Ltd. A key intermediate for preparing glucopyranosyl derivatives and preparation method thereof
WO2026042861A1 (ja) * 2024-08-21 2026-02-26 セトラスホールディングス株式会社 ジアセトングルコースのケトン体及びジアセトンアロースの製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03006514A (es) * 2001-01-22 2004-12-02 Merck & Co Inc Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico.
JP2005511764A (ja) * 2001-12-14 2005-04-28 アルコン，インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−５−オール化合物
US7323453B2 (en) * 2002-02-13 2008-01-29 Merck & Co., Inc. Methods of inhibiting orthopoxvirus replication with nucleoside compounds
BR0309581A (pt) * 2002-05-06 2005-03-29 Genelabs Tech Inc Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US20040259934A1 (en) * 2003-05-01 2004-12-23 Olsen David B. Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
JP2007509939A (ja) * 2003-10-27 2007-04-19 ジェネラブズ テクノロジーズ インコーポレーティッド ウイルス感染を治療するためのヌクレオシド化合物

Also Published As

Publication number Publication date
MX2009008495A (es) 2009-08-20
TW200838550A (en) 2008-10-01
AR065249A1 (es) 2009-05-27
EP2132216A1 (en) 2009-12-16
CN101600726B (zh) 2013-03-27
PT2132216E (pt) 2012-02-20
US8278282B2 (en) 2012-10-02
PE20090070A1 (es) 2009-03-19
CL2008000409A1 (es) 2008-08-29
ES2381093T3 (es) 2012-05-23
EP2132216B1 (en) 2011-11-16
JP2010518047A (ja) 2010-05-27
ATE533774T1 (de) 2011-12-15
BRPI0807222A2 (pt) 2014-04-29
WO2008095993A1 (en) 2008-08-14
CA2675462A1 (en) 2008-08-14
KR20090109102A (ko) 2009-10-19
CN101600726A (zh) 2009-12-09
US20100227833A1 (en) 2010-09-09
AU2008212752A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
MX2009008495A (es) Novedosos analogos de nucleosidos para el tratamiento de infecciones virales.
MX2022015257A (es) Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas.
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
EA200970916A1 (ru) Соединения 5,6-дигидро-1н-пиридин-2-она
EA201690265A3 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA201190178A1 (ru) Замещённые нуклеозидные и нуклеотидные аналоги
MD4584B1 (ro) (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzil)carbamoil)-2,3,4,5,7,9,13,13a-octahidro-2,5-metanopirido[1ʹ,2ʹ:4,5]pirazino[2,1-b][1,3]oxazepin-8-olat de sodiu
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
EA201491505A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
MX2015014890A (es) Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados.
EA201592184A1 (ru) 4'-фтор-2'-метилзамещенные нуклеозидные производные
EA201592075A1 (ru) Замещенные нуклеозиды, нуклеотиды и их аналоги
MX2020002151A (es) Compuestos antivirales.
EA200901490A1 (ru) Химические соединения
CA3010327A1 (en) Aryl substituted pyrimidines for use in influenza virus infection
GEP20227457B (en) Nucleotide hemi-sulfate salt for treatment of hepatitis c virus
ATE488232T1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
WO2010053573A3 (en) Screen for inhibitors of filovirus and uses therefor
PH12018502332A1 (en) Stabilized pre-fusion rsv f proteins
EA200701297A1 (ru) Соединения пиридазинона
CY1118399T1 (el) Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c
MX2016003135A (es) Compuestos de piridazinona y usos de los mismos.
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
EA201892448A1 (ru) Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения